» Articles » PMID: 19587609

Effect of Vitamin D on Blood Pressure: a Systematic Review and Meta-analysis

Overview
Journal J Hypertens
Date 2009 Jul 10
PMID 19587609
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Vitamin D insufficiency has been linked to hypertension and cardiovascular events in observational studies. It is unclear whether vitamin D supplementation can reduce blood pressure, and, if so, by how much.

Methods: We performed a systematic review and meta-analysis to examine whether vitamin D reduces blood pressure. Databases including MEDLINE, EMBASE, the Cumulative Index to Nursing and Allied Health Literature and the Cochrane library were searched, supplemented by searches of grey literature, unpublished trials and references from included studies. Studies were assessed by two reviewers independently according to a prespecified protocol. Interventions included activated vitamin D, unactivated vitamin D2 and D3 and ultraviolet B radiation.

Results: Eleven randomized, controlled trials fulfilled the inclusion criteria. Studies were small and of variable methodological quality. Mean baseline blood pressure was more than 140/90 mmHg in eight studies. Meta-analysis of these eight studies showed a nonsignificant reduction in systolic blood pressure in the vitamin D group compared with placebo [-3.6 mmHg, 95% confidence interval (CI) -8.0 to 0.7]. A small, statistically significant reduction was seen in diastolic blood pressure (-3.1 mmHg, 95% CI -5.5 to -0.6). Subgroup analysis suggested that unactivated vitamin D produced a greater fall in systolic blood pressure than activated vitamin D (-6.2 mmHg, 95% CI -12.32 to -0.04, vs. +0.7 mmHg, 95% CI -4.8 to 6.2). No reduction in blood pressure was seen in studies examining patients who were normotensive at baseline.

Conclusion: We found weak evidence to support a small effect of vitamin D on blood pressure in studies of hypertensive patients.

Citing Articles

Unveiling the benefits of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients.

Loh H, Tay S, Koa A, Yong M, Said A, Chai C J Transl Med. 2025; 23(1):296.

PMID: 40055713 PMC: 11889775. DOI: 10.1186/s12967-025-06312-w.


Calcium, magnesium, and vitamin D supplementations as complementary therapy for hypertensive patients: a systematic review and meta-analysis.

Amer S, Abo-Elnour D, Abbas A, Abdelrahman A, Hamdy H, Kenawy S BMC Complement Med Ther. 2025; 25(1):89.

PMID: 40045266 PMC: 11884002. DOI: 10.1186/s12906-025-04809-x.


A Personalized Approach to Vitamin D Supplementation in Cardiovascular Health Beyond the Bone: An Expert Consensus by the Italian National Institute for Cardiovascular Research.

Mattioli A, Coppi F, Severino P, Penna C, Pagliaro P, Dei Cas A Nutrients. 2025; 17(1.

PMID: 39796548 PMC: 11722835. DOI: 10.3390/nu17010115.


Associations of Vitamin D-Related Biomarkers With Hypertension and the Renin-Angiotensin System in Men and Women.

Wang L, Cook N, Manson J, Gaziano J, Buring J, Sesso H Am J Hypertens. 2024; 37(12):953-961.

PMID: 39120701 PMC: 11565204. DOI: 10.1093/ajh/hpae103.


The relationship between serum 25-hydroxy vitamin D status and hypertension in Syrian population: retrospective cohort study.

Bakkar N, Bakr A, Alhusseini A, Alourfi Z Ann Med Surg (Lond). 2024; 86(6):3222-3226.

PMID: 38846846 PMC: 11152839. DOI: 10.1097/MS9.0000000000001989.